Literature DB >> 18097124

Risedronate induced transient ocular myasthenia.

V Raja, P Sandanshiv, M Neugebauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18097124     DOI： 10.4103/0022-3859.37525

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN： 0022-3859            Impact factor:   1.476


× No keyword cloud information.
  3 in total

Review 1.  Selected lid problems in neurologic practice.

Authors:  Gregory S Kosmorsky; Alyssa Fiddler
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Exacerbation of myasthenia gravis by alendronate.

Authors:  S Kesikburun; U Güzelküçük; S Alay; F Yavuz; A K Tan
Journal:  Osteoporos Int       Date:  2014-06-17       Impact factor: 4.507

Review 3.  Risedronate-associated scleritis: a case report and review of the literature.

Authors:  Iman Hemmati; John Wade; John Kelsall
Journal:  Clin Rheumatol       Date:  2012-08-05       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.